Using deep brain stimulation to treat cognitive dysfunction in Parkinson's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate how electrical stimulation of the substantia nigra can regulate cognitive dysfunction in patients with Parkinson's disease. It employs a self-controlled prospective cohort design, comparing memory performance and brain activity before and after deep brain stimulation (DBS) surgery. The study will involve 60 participants aged 50-70 who meet specific inclusion criteria, and it will analyze the effects of microelectrode stimulation on cognitive functions over time. The goal is to reveal the electrophysiological mechanisms underlying the impact of DBS on memory networks.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Voluntarily participate in the clinical study and sign the informed consent;
* Age 50-70 years old, gender unlimited;
* The clinical diagnosis is consistent with typical PD, and the medical history is less than 20 years;
* Patients who intend to use 3.0T magnetic resonance compatible dual-channel DBS device (G106R or G106RS, Beijing Pinchi Company) for bilateral subthalamic nucleus DBS surgery to control PD symptoms;
* MRI excluded patients with obvious structural changes;
* The visual acuity and hearing of the subjects were basically normal, and the compliance was good, and they could complete the tasks listed in the experimental scheme in accordance with the standards.

Exclusion Criteria:

* Serious mental, cognitive and psychological disorders, unable to sign informed consent or cooperate with the operation and various tasks;
* There are contraindications for neurosurgery, such as hydrocephalus, cerebral atrophy, cerebrovascular sequelae, heart disease and other cardiovascular and cerebrovascular diseases;
* There are concomitant diseases that seriously affect health, such as tumors, serious abnormalities of liver and kidney function (indexes more than 3 times normal);
* There is intracranial space occupation, cerebrovascular disease, mental illness, other neurological diseases, claustrophobia, or there is an implant in the body, which affects the nuclear magnetic scan;
* The results of the Mini-Mental State Scale (MMSE) \<24 or the Montreal Cognitive Assessment Scale (MoCA) \<18 in the preoperative assessment, or the results of other scales indicate the presence of severe dementia.

Where it's running

• Beijing Tiantan Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: lin shi, M.D.
• Email: shilin2015@foxmail.com
• Phone: 008615210466780

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MAO-B PET/CT imaging in Parkinson’s-related diseases

  This study tests whether 18F-FPyCO/SMBT-1 PET/CT can help diagnose Parkinson’s-related conditions by measuring lesion uptake in patients with PD, PD dementia, or parkinsonism.

  Recruiting at 3 sites Tianjin Medical University · Hefei, Anhui and 2 other locations · NCT07685873

• Sleep and DBS: Testing Deep Brain Stimulation Effects on Sleep in Parkinson’s

  This study tests how turning the Deep Brain Stimulation device on or off affects sleep quality in people with Parkinson’s who already have a DBS implant.

  Recruiting The University of Texas Health Science Center at San Antonio · San Antonio, Texas · NCT07636720

• Detecting phosphorylated alpha-synuclein in colon tissue to help diagnose Parkinson's

  This study will test whether routine colonoscopy tissue samples from adults with Parkinson's show phosphorylated alpha-synuclein, a protein linked to the disease.

  Recruiting CND Life Sciences · Portland, Oregon · NCT07204652

• tDCS to improve swallowing in Parkinson's disease

  This study tests whether adding transcranial direct current stimulation (tDCS) to standard swallowing therapy helps people with Parkinson's disease who have dysphagia.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07153692

• Investigating how deep brain stimulation affects sleep in Parkinson's disease

  This study is testing how deep brain stimulation affects sleep in people with Parkinson's disease to see if it can help improve their sleep quality.

  Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT06914466

• Improving balance in Parkinson's disease using blood flow restriction

  This study is testing whether using blood flow restriction during balance exercises can help people with Parkinson's disease improve their walking, balance, and endurance.

  Recruiting The University of Texas Health Science Center at San Antonio · San Antonio, Texas · NCT06508801

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.